Forest Laboratories, Inc. (FRX) To Present Data About Aclidinium, Aclidinium/Formoterol Combination, And Roflumilast At The American Thoracic Society International Conference
5/19/2014 6:42:41 AM
Forest Laboratories, Inc. (NYSE:FRX) today announced that it will present data on aclidinium, aclidinium/formoterol combination, and roflumilast at the American Thoracic Society (ATS) 2014 International Conference scheduled for May 16-21, 2014, in San Diego. Ten posters and two poster discussion sessions will be presented for aclidinium and aclidinium/formoterol. Roflumilast data will be highlighted in four posters and one mini symposia presentation.
Help employers find you! Check out all the jobs and post your resume.
comments powered by